Vascular Graft Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Vascular Graft Market is segmented By Product (Hemodialysis Access Graft, Endovascular Aneurysm Repair Stent Graft, and Peripheral Vascular Graft), By Raw Material (Polyester, Polytetrafluoroethylene (PTFE), Polyurethane, and Biosynthetic), By End-User (Hospitals and Ambulatory Surgical Centers (ASCs)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Vascular Graft Market Size

The Global Vascular Graft Market reached USD 2,483.29 million in 2022 and is projected to witness lucrative growth by reaching up to USD 4,404.04 million by 2031. The market is expected to exhibit a CAGR of 7.6% during the forecast period (2024-2031).

A vascular graft (or) vascular bypass is a surgical procedure that is used to redirect blood flow from one area to another by reconnecting blood vessels, also known as a channel used to replace the diseased or blocked blood vessels.

It can be arteries, veins, or capillaries. Vascular grafts have their application in treating cardiovascular diseases, kidney failure, vascular occlusion, and others. The global vascular graft market will accelerate due to an increase in the number of cardiovascular diseases, coronary artery disease, diabetes, and the requirement of artificial vessel implantations.

Vascular Graft Market Summary

For more insights - Request Free Sample

Vascular Graft Market Growth

Increasing Incidence of Cardiovascular Disease Will Drive the Vascular Graft Market Growth

Cardiovascular disease (CVDs) is the major driver for the vascular graft market growth, because as CVD progresses there is narrowing of arteries and veins, which causes blockage of blood vessels, thereby reducing the blood flow towards the vital organs in the body. This might lead to serious compications such as heart attack, coronary artery diseases, and heart stroke. 

For instance, in October 2022, heart disease is the leading cause of the death, where approximately 697,000 people lead to death in U.S., almost after every 34 seconds 1 person leads to death in U.S. by cardiovascular disease. Vascular graft play an important role, which is used to bypass the damaged blood vessels, thereby continuing the blood flow. Therefore, owing to the above factor, the market for vascular graft will have boost over the forecast period.

The Growing Geriatric Population Will Create Lucrative Opportunities for Global Vascular Graft Market Growth

The growing geriatric population, which is more prone to cardiovascular diseases such as peripheral artery disease, coronary artery disease, and aortic aneurysm, will propel the global vascular graft market growth. For instance, according to 2022 report of World Health Organization (WHO) by 2030, 1 in 6 of the world's population will be 60 years or older, with the number of individuals in this age group increasing from 1 billion in 2020 to 1.4 billion. Additionally, by 2050, the global population of people aged 60 years and above is expected to double to 2.1 billion.

Furthermore, the advancements in technoogies have made the vascular graft procedure more effective and less invasive, thereby enabling the older people to take procedures with lesser complications. Hence, the growing geriatric population will create major impact on the global vascular graft market gorwth over the forecast period,

Product Failures And Recalls Will Hamper The Market Growth Over the Forecast Period

Product failures can have serious, even fatal, consequences for people. Several products offered by companies have been recalled from the market over the years due to product malfunctions or other issues. Market trends harm end-user perceptions of graft safety, affecting their utilisation in treatment procedures. This factor will impede global vascular graft market expansion throughout the forecast period.

COVID-19 Impact on Vascular Graft Market Growth

The COVID-19 pandemic had a potential impact on the vascular grafts market. One of the major impacts of the pandemic has been the disruption of supply chains, which has resulted in delays in production and delivery. Additionally, the decrease in elective surgeries has led to a decline in the number of vascular graft procedures being performed. 

However, there have also been some opportunities for growth in the vascular grafts market during the pandemic, such as the increased focus on telemedicine and remote patient monitoring, and the development of new and innovative vascular grafts that can improve patient outcomes and reduce the risk of complications. Overall, the COVID-19 pandemic has had a mixed impact on the global vascular grafts market.

Russia Ukraine Conflict Analysis

The Russia and Ukraine conflict had a limited impact on the global vascular grafts market. As the conflict has led to geopolitical tensions and economic sanctions, but the market for vascular grafts is not heavily dependent on either Russia or Ukraine for manufacturing or distribution. Most of the major players in the vascular grafts market are multinational companies with operations and supply chains spread across different regions of the world. 

Vascular grafts are used primarily in medical procedures, and the demand for these devices is largely driven by patient needs and healthcare policies rather than geopolitical factors. Any disruptions to the supply of vascular grafts due to the Russia-Ukraine conflict are likely to be temporary and limited in scope, but any prolonged conflict or instability in the region could have wider implications for the global healthcare industry, including the vascular grafts market.

Vascular Graft Market Segment Analysis

The global vascular graft market is segmented based on product, raw material, end user, and region.

The Hospitals Segment is Expected to Dominate the Global Vascular Graft Market.

The hospitals sgement dominated the global vascular graft market and accounted for the highest market share of 38.3%. Vascular grafting is one of the many surgical procedures that have become more common in hospitals as a result of the rising burden of chronic illnesses including cardiovascular disease and chronic renal disease. As a result, hospitals make up the majority of vascular transplant end users.

The expansion of the hospital end user sector is also being fueled by the availability of public and private insurance programmes for hospital treatments. Vascular graft surgeries can be obtained by patients through insurance plans, which increases their accessibility and affordability. Therefore, owing to the above factors, the hospitals segment is likely to play major role in accelarating the global vascular graft market growth.

Source: DataM Intelligence Analysis (2023)

Vascular Graft Market Geographical Share

North America Region Holds the Largest Market Share of the Global Vascular Graft Market

North America is expected to hold a dominant position in the global vascular graft market clinching 1/3rd share of the total market, owing to the factors such as the high prevalence rate of diabetes, cardiovascular diseases, and chronic kidney disease. 

The presence of reimbursement coverage and availability of state-of-the-art healthcare infrastructure are driving the growth of this market in North America. Constant technological developments followed by discoveries of specific tissue-engineered products trigger the growth of biomaterials vascular grafts. 

Key factors attributing to the market growth include better reimbursement policies, advanced technological facilities, successful initiatives, and accurate diagnostic procedures through biometric tools. Furthermore, ongoing research about the development of advanced biomaterial grafts is expected to heighten the demand for these products in the region. 

Source: DataM Intelligence Analysis (2023)

Vascular Graft Companies

The major global players in the market include Abbott Laboratories, Braun Melsungen AG, Bard Peripheral Vascular Inc., Cardinal Health (Cordis Corporation), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic PLC, and W.L. Gore & Associates.

Key Developments

• In May 2022, Aijun Wang, a UC Davis professor, received a D 3 million California Institute for Regenerative Medicine (CIRM) grant for the development of a smart durable vascular device for hemodialysis patients with renal failure.
• In August 2022, InnAVasc Medical, a privately held medical technology company, was acquired by W. L. Gore & Associates, a global material science company committed to transforming industries and improving lives. InnAVasc Medical is focused on improving care for patients with end-stage renal disease who receive dialysis treatment using graft circuits. 
• In April 2023, the first-in-human (FIH) aXess vascular graft trial (NCT04898153) was presented at the 13th Congress of the Vascular Access Society in Porto, Portugal by Xeltis, a developer of transformative implants company that allow the natural synthesis of living and durable vessels and valves. The results from the first six months of the trial were extremely encouraging.

Why Purchase the Report?

• To visualize the global vascular graft market segmentation based on product, raw material, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of global vascular graft market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global vascular graft market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies